Immunocore Holdings (IMCR) Notes Payables (2019 - 2023)

Immunocore Holdings (IMCR) has reported Notes Payables for 2 consecutive years, with $1.2 million the latest figure, recorded in Q2 2023.

• Quarterly Notes Payables changed N/A year-over-year to $1.2 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $1.2 million (changed N/A YoY) and the FY2019 annual result came in at $24.6 million, changed N/A from the prior year.
• Notes Payables eased to $1.2 million in Q2 2023 per IMCR's latest filing, from $24.6 million in the prior quarter.
• Over the last five years, Notes Payables for IMCR reached as high as $24.6 million in Q4 2019 and fell as low as $1.2 million in Q2 2023.